A shortage of staff that can administer monoclonal antibodies, which have to be given via IV, combined with delays in Covid-19 testing have limited their use.
from Health and Science https://ift.tt/3nRTviw
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH
No comments:
Post a Comment